Results 151 to 160 of about 12,621 (239)

Complement C1 Esterase Inhibitor Measurement [PDF]

, 2020
openaire   +1 more source

Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity. [PDF]

Clin Immunol, 2016
Colonna L, Parry GC, Panicker S, Elkon KB.   +3 more
europepmc   +1 more source

Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial.

Blood, 2019
Jäger U, D'Sa S, Schörgenhofer C, Bartko J, Derhaschnig U, Sillaber C, Jilma-Stohlawetz P, Fillitz M, Schenk T, Patou G, Panicker S, Parry GC, Gilbert JC, Jilma B.   +13 more
europepmc   +1 more source

Response to the Letter to the Editor Entitled "Defining "Dominance" in Atypical Hemolytic Uremic Syndrome: Distinguishing Amplification From Initiation". [PDF]

Kidney Int Rep
Aiello S, Santarsiero D, Gastoldi S, Benigni A, Remuzzi G, Noris M.   +5 more
europepmc   +1 more source

Oxygen-dependent modulation of the human complement system during acute normobaric hypoxia: a translational plasma proteomics study. [PDF]

Clin Exp Med
Lang A, Pang TY, Piel S, Oehler D, Zweck E, Shahrjerdi K, Okkasian M, Georgy J, Reinders Y, Duplessis AJ, Tank J, Jordan J, Pfeiler S, Sickmann A, Kelm M, Jung C, Gerdes N.   +16 more
europepmc   +1 more source

Targeting C1q signaling in fibro-adipogenic progenitors prevents regenerative fibrosis of aged muscle. [PDF]

Proc Natl Acad Sci U S A
Kanugovi A, Aguiari P, Choi R, Kim S, Wu D, De Morree A, Bui S, Lam R, Biressi S, Liu L, Rando TA.   +10 more
europepmc   +1 more source

Complement system in cancer: friend or foe of immunotherapy. [PDF]

J Immunother Cancer
Shah HK, Prem S, Wu X, Liszewski MK, Atkinson JP, Singh AK, Kapoor V.   +6 more
europepmc   +1 more source

Complement C3 recognition by C3 convertases. [PDF]

Sci Adv
Jia C, Yang X, Zhao MH, Tan Y, Xiao J.
europepmc   +1 more source

Exploring the role of C1-inhibitor in thrombotic diseases. [PDF]

Blood Adv
Hansen JB.
europepmc   +1 more source

Comment on "Could signal peptide complement C1r/C1s, Uegf, and Bmp1, and epidermal growth factor-containing protein 1 be a therapeutic target in the pathogenesis of preeclampsia?" [PDF]

Rev Assoc Med Bras (1992)
Cheng C, Wang Y.
europepmc   +1 more source